Literature DB >> 32863005

Corrigendum to "Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study" [Life Sci. 253 (2020) 117592].

Abdo A Elfiky1.   

Abstract

Entities:  

Year:  2020        PMID： 32863005      PMCID： PMC7957227          DOI： 10.1016/j.lfs.2020.118350

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
The author regrets that the article omitted to clarify that parts of Sections 2.1, 2.2, 3.1 and 3.2, as well as of Figs. 1 and 2 were reused from the article that was previously published by the author in Life Sciences 248 (2020) 117477 https://doi.org/10.1016/j.lfs.2020.117477. The author would like to apologise for any inconvenience caused.
  7 in total

1.  Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective.

Authors:  Mohammed A Abosheasha; Afnan H El-Gowily; Abdo A Elfiky
Journal:  J Thromb Thrombolysis       Date:  2021-09-12       Impact factor: 5.221

2.  Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.

Authors:  Jiapan Gao; Yuanyuan Ding; Yuejin Wang; Peida Liang; Liyang Zhang; Rui Liu
Journal:  Phytother Res       Date:  2021-02-15       Impact factor: 6.388

3.  Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase.

Authors:  Abdo A Elfiky; Hanan A Mahran; Ibrahim M Ibrahim; Mohamed N Ibrahim; Wael M Elshemey
Journal:  RSC Adv       Date:  2022-01-20       Impact factor: 3.361

4.  Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.

Authors:  Yukihiro Yoshimura; Nobuyuki Miyata; Hiroaki Sasaki; Aya Shiba; Masaharu Aga; Yusuke Hamakawa; Yuri Taniguchi; Yuki Misumi; Yoko Agemi; Tsuneo Shimokawa; Hiroaki Okamoto; Natsuo Tachikawa; Kazuhito Miyazaki
Journal:  Sci Rep       Date:  2022-03-29       Impact factor: 4.379

Review 5.  Biomedical and Antioxidant Potentialities in Chilli: Perspectives and Way Forward.

Authors:  Solanki Bal; Amit Baran Sharangi; Tarun Kumar Upadhyay; Fahad Khan; Pratibha Pandey; Samra Siddiqui; Mohd Saeed; Hae-Jeung Lee; Dharmendra K Yadav
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

6.  Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.

Authors:  Motonori Tsuji
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

7.  The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.

Authors:  Abdo A Elfiky; Eman B Azzam; Medhat W Shafaa
Journal:  Mol Divers       Date:  2021-01-03       Impact factor: 3.364
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.